Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis P Jimenez-Uribe

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncoscience|March 20, 2026
Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potentialMelina A Dattilo, Marina G Ferrari, Alexis P Jimenez-Uribe, et al.
Journal of the American Society of Nephrology : JASN|August 8, 2025
Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble FactorsRyan Spear, Alexis P Jimenez-Uribe, Yanxia Cao, et al.
Oncogene|December 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic targetMarina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncoscience|March 20, 2026
Targeting MD2 in prostate cancer bone metastasis: Mechanistic insights and therapeutic potentialMelina A Dattilo, Marina G Ferrari, Alexis P Jimenez-Uribe, et al.
Journal of the American Society of Nephrology : JASN|August 8, 2025
Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble FactorsRyan Spear, Alexis P Jimenez-Uribe, Yanxia Cao, et al.
Oncogene|December 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic targetMarina G Ferrari, Alexis P Jimenez-Uribe, Li Wang, et al.
Pageof 1